Reliability of a freehand three-dimensional ultrasonic device allowing anatomical orientation “at a glance”: Study protocol for 3D measurements with Curefab CS®
3D ultrasonic measurement of carotid atherosclerotic lesions is a vital tool for research and patient management. This study evaluates the accuracy and reliability of the Curefab CS®, a magnetically tracked freehand 3D ultrasonic device designed for rapid reconstruction and intuitive anatomical orientation. By addressing calibration reproducibility, absolute system accuracy, and direct comparison with CT and MRI modalities, the researchers demonstrate the system's clinical potential for high-precision diagnostic imaging.
Introduction: The Challenge of 2D Ultrasound
While ultrasound is a staple of non-invasive diagnostics, conventional 2D imaging presents significant hurdles when assessing complex anatomy like carotid atherosclerotic plaques. Clinicians often must perform "mental gymnastics" to reconstruct 3D structures from multiple 2D slices, a process prone to error and poor reproducibility. Existing 3D solutions are often either expensive, specialized probes with limited fields of view or complex research systems requiring extensive training. The Curefab CS® offers a middle ground: a "freehand" 3D system that can be retrofitted to any standard ultrasound machine, providing rapid reconstruction and intuitive anatomical orientation.
System Architecture and Methods
The Curefab CS system integrates three core components to provide high-precision imaging:
Hardware Integration: A high-precision frame grabber captures video from a standard ultrasound machine, while an electromagnetic (EM) tracking system (Ascension DriveBAY) monitors the position and orientation of sensors attached to the probe.
GPU-Accelerated Reconstruction: The system utilizes a pairwise backward interpolation algorithm. By processing consecutive frames in parallel on the GPU, it achieves nearly real-time volume reconstruction, allowing for orientation "at a glance."
Figure 1: Overview of the Curefab CS system workflow, integrating 2D ultrasound data with navigation system position information to generate 3D volumes and visualizations.
To ensure the system accurately maps the 2D image into 3D space, a "pyramid phantom"—a precisely machined aluminum tetrahedron—is used. By scanning this phantom from multiple angles, the software calculates the spatial transformation between the EM sensor and the ultrasound image plane. This ensures that every pixel captured by the probe is correctly localized in the final 3D volume.
Figure 2: Diagram of the calibration process using a pyramid phantom to establish spatial transformations between the ultrasound probe and the tracking system.
The system was validated through a series of rigorous tests involving point phantoms (metal wires in water) and tube phantoms with fixed landmarks. The results place the Curefab CS at the top tier of freehand 3D ultrasound performance:
Calibration Precision: The mean error for locating the center and corners of the image plane ranged from 0.13 mm to 0.24 mm, outperforming many previously reported methods which often range up to 2.75 mm.
Point Accuracy: The system achieved a mean point reconstruction accuracy of 1.52 mm, compared to values ranging from 1.67 mm to 3.63 mm in existing literature.
Distance Accuracy: The mean total error for distance measurements was just 0.9% (SD 0.56%), proving that 3D reconstruction maintains measurement integrity comparable to, or better than, standard 2D imaging.
Furthermore, 3D ultrasound records were compared to CT and MRI scans, showing promising results for future diagnostic tools that integrate multiple imaging modalities for patient follow-up.
Conclusion
The study demonstrates that 3D measurements with Curefab CS are feasible, reliable, and accurate. The system’s ability to connect to any conventional machine via standard video outputs makes it a cost-effective upgrade for clinical workflows. Future applications may include the use of planimetrics to measure carotid plaque volume and identify vulnerable plaques, a critical metric for predicting stroke risk that is difficult to capture accurately in 2D.
Summary updated
Abstract
Background and Purpose: 3D ultrasonic measurement of carotid atherosclerotic lesions has emerged as an important tool for research and patient management. We sought to evaluate the accuracy and the reliability of a new easy-to-use magnetically tracked freehand 3D ultrasonic device with quick reconstruction time, allowing for anatomical orientation “at a glance” for calibration and distance measurements, with unique usability as a combined tool for image acquisition, registration and measurement within 3-D ultrasonic (US) volumes, which is furthermore connectable to every conventional US-machine. To enable a complete evaluation of the whole system, three different key points had to be addressed: the reproducibility of the calibration procedure, the absolute accuracy of the whole system and a direct comparison to CT and MRI imaging modalities. Materials and Methods: For validating our calibration method, a set of 6 calibrations was performed; each consisting of 6 records of a pyramid phantom taken from different positions and angles. To evaluate the accuracy of the whole 3D-ultrasound system, the point reconstruction accuracy and the distance accuracy were determined in a point phantom made out of a single metal wire vertically attached to the bottom of a plastic tub filled with water. For distance measurements, a precisely manufactured plastic tube phantom was scanned and the length between fixed landmarks on the tube was measured. In a final step, 3D US records acquired with Curefab CS were compared to CT and MRI scans; for this purpose all ultrasonic data was manually registered to the CT/MRI data. Results: Concerning calibration precision the tested Curefab CS system performs state of the art compared to reviews of recent freehand 3D-Ultrasound calibration methods. The point reconstruction measure for evaluation of system accuracy retrieved a mean point accuracy of 1.52 mm in contrast to values ranging from 1.67 to 3.63 mm. Mean total error of distance measurements was 0.9% with standard deviation 0.56% in our study, compared with values reaching from about 1% up to 2.3% in other studies on this subject. All quantitative measurement results are listed in a summarized form in Table 1. Besides quantitative evaluation, 3D-ultrasound records acquired with the Curefab CS system were also compared to CT and MRI scans of patients (see Figure 3 and Figure 4). The alignment of both image modalities showed promising results for future development of diagnostic tools using all image data. Discussion and Conclusion: Our study demonstrates that 3D measurements with Curefab CS are feasible with satisfactory reliability and accuracy. From the results gathered in our study we conclude that 3D-imaging with Curefab CS might start off the possibility of accurate visualization, volume measurement, carotid plaque characterization and identification of vulnerable plaques in the very near future.
BibTeX
@article{feurer2012reliability,
author = {Regina Feurer and Christoph Hennersperger and J.B. Runyan and C.L. Seifert and J. Pongratz and Mark Wilhelm and Jaroslav Pelisek and Nassir Navab and Else Marie Bartels and H. Poppert},
title = {{Reliability of a freehand three-dimensional ultrasonic device allowing anatomical orientation “at a glance”: Study protocol for 3D measurements with Curefab CS®}},
journal = {Journal of Biomedical Graphics and Computing},
year = {2012},
doi = {10.5430/jbgc.v2n2p1},
}